Calcineurin Inhibitors Modulate CXCR3 Splice Variant Expression and Mediate Renal Cancer Progression

Calcineurin inhibitors (CNI) are used to prevent inflammatory diseases and allograft rejection. However, little is known about the mechanism(s) underlying their ability to promote the development and recurrence of cancer. Recent studies suggested that the chemokine receptor CXCR3 may play important...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Hauptverfasser: Datta, Dipak, Contreras, Alan G., Grimm, Martin, Waaga-Gasser, Ana Maria, Briscoe, David M., Pal, Soumitro
Format: Artigo
Sprache:Inglês
Veröffentlicht: American Society of Nephrology 2008
Schlagworte:
Clinical Research
Online Zugang:https://ncbi.nlm.nih.gov/pmc/articles/PMC2588111/
https://ncbi.nlm.nih.gov/pubmed/18832436
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1681/ASN.2008040394
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!

Ähnliche Einträge